SLC12A2 and ischemic stroke: Pharmacological inhibition or a genetic deficiency of NKCC1 decreases BBB breakdown, brain edema and retains TJ protein integrity [47], but the role of NKCC1 in the ChP blood–CSF barrier after ischemic stroke has received little attention.